Cargando…
Versican G3 Domain Modulates Breast Cancer Cell Apoptosis: A Mechanism for Breast Cancer Cell Response to Chemotherapy and EGFR Therapy
Overexpression of EGFR and versican has been reported in association with breast cancers. Considered oncogenic, these molecules may be attractive therapeutic targets. Possessing anti-apoptotic and drug resistant properties, overexpression of these molecules is accompanied by selective sensitization...
Autores principales: | Du, William Weidong, Yang, Burton B., Yang, Bing L., Deng, Zhaoqun, Fang, Ling, Shan, Sze Wan, Jeyapalan, Zina, Zhang, Yaou, Seth, Arun, Yee, Albert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212514/ https://www.ncbi.nlm.nih.gov/pubmed/22096483 http://dx.doi.org/10.1371/journal.pone.0026396 |
Ejemplares similares
-
Correction: Versican G3 Domain Modulates Breast Cancer Cell Apoptosis: A Mechanism for Breast Cancer Cell Response to Chemotherapy and EGFR Therapy
por: Du, William Weidong, et al.
Publicado: (2012) -
The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro – evaluation towards understanding breast cancer cell bone metastasis
por: Du, William Weidong, et al.
Publicado: (2012) -
Expression of Versican 3′-Untranslated Region Modulates Endogenous MicroRNA Functions
por: Lee, Daniel Y., et al.
Publicado: (2010) -
Versican G3 Promotes Mouse Mammary Tumor Cell Growth, Migration, and Metastasis by Influencing EGF Receptor Signaling
por: Du, William Weidong, et al.
Publicado: (2010) -
The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis
por: Yee, Albert JM, et al.
Publicado: (2007)